Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interest of the T2 * Sequence in MRI for the Diagnosis of Migraine Aura in the Acute Phase.

NCT03689361 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT03689361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03689361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interest of the T2 * Sequence in MRI for the Diagnosis of Migraine Aura in the Acute Phase.
Lead sponsor
University Hospital, Toulouse
Phase
Phase 4
Overall status
Completed
Start date
December 22, 2018
Completion date
December 11, 2020
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine aura